AI in biotech is becoming standard. That makes differentiation harder. As more companies use the same label, the real challenge is no longer getting attention, but being understood. Clear positioning and messaging now matter more than the AI claim alone.
Many CROs describe their capabilities well, but still struggle to stand out. This article explores what life science companies are really evaluating when they choose a CRO, where CRO messaging often goes wrong, and how clearer positioning can lead to better-fit conversations.
What does marketing actually mean for a biotech startup? This article breaks down how positioning, messaging, investor communication, digital marketing, and visibility work together to support growth.